tradingkey.logo

Codexis Inc

CDXS
2.035USD
-0.115-5.35%
Fechamento 11/06, 16:00ETCotações atrasadas em 15 min
183.67MValor de mercado
PerdaP/L TTM

Mais detalhes de Codexis Inc Empresa

Codexis, Inc. is an enzyme engineering company. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins. It utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) therapeutics through an enzymatic route. It also uses the CodeEvolver platform technology to develop enzymes for the synthesis of nucleic acids, such as DNA/RNA, including enzymes utilized in its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Informações de Codexis Inc

Código da empresaCDXS
Nome da EmpresaCodexis Inc
Data de listagemApr 22, 2010
CEODr. Stephen G. Dilly, Ph.D.
Número de funcionários188
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 22
Endereço200 Penobscot Dr
CidadeREDWOOD CITY
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94063
Telefone16504218100
Sitehttps://www.codexis.com/
Código da empresaCDXS
Data de listagemApr 22, 2010
CEODr. Stephen G. Dilly, Ph.D.

Executivos da empresa Codexis Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
+26.74%
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+10.73%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
147.90K
+38.33%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
132.05K
+45.00%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
+46.54%
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
+57.58%
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
Executive Vice President, Chief Technical Officer
Executive Vice President, Chief Technical Officer
92.46K
-6.32%
Dr. Raymond De Vre, Ph.D.
Dr. Raymond De Vre, Ph.D.
Independent Director
Independent Director
88.83K
+85.66%
Mr. Christos Richards
Mr. Christos Richards
Independent Director
Independent Director
85.13K
+92.83%
Ms. Georgia L. Erbez
Ms. Georgia L. Erbez
Chief Financial Officer
Chief Financial Officer
70.64K
-8.12%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
+26.74%
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+10.73%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
147.90K
+38.33%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
132.05K
+45.00%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
+46.54%
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
+57.58%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
APAC
6.58M
42.93%
America
6.35M
41.44%
EMEA
2.40M
15.63%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Opaleye Management Inc.
13.97%
Casdin Capital, LLC
7.98%
BlackRock Institutional Trust Company, N.A.
6.48%
The Vanguard Group, Inc.
5.08%
Fidelity Management & Research Company LLC
4.82%
Outro
61.67%
Investidores
Investidores
Proporção
Opaleye Management Inc.
13.97%
Casdin Capital, LLC
7.98%
BlackRock Institutional Trust Company, N.A.
6.48%
The Vanguard Group, Inc.
5.08%
Fidelity Management & Research Company LLC
4.82%
Outro
61.67%
Tipos de investidores
Investidores
Proporção
Investment Advisor
28.84%
Hedge Fund
28.38%
Investment Advisor/Hedge Fund
19.18%
Individual Investor
2.59%
Research Firm
1.18%
Pension Fund
0.20%
Bank and Trust
0.18%
Venture Capital
0.05%
Insurance Company
0.03%
Outro
19.36%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
257
69.82M
77.34%
-3.13M
2025Q2
284
75.27M
90.86%
-6.81M
2025Q1
321
69.35M
83.91%
-9.24M
2024Q4
334
67.97M
82.44%
-9.17M
2024Q3
341
66.67M
93.65%
-3.04M
2024Q2
355
56.24M
79.41%
-16.85M
2024Q1
368
57.66M
81.73%
-20.93M
2023Q4
384
58.98M
84.48%
-18.95M
2023Q3
392
59.46M
85.28%
-19.41M
2023Q2
387
64.66M
96.86%
-12.85M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Opaleye Management Inc.
12.61M
13.97%
+10.00K
+0.08%
Jul 30, 2025
Casdin Capital, LLC
7.20M
7.98%
-900.00K
-11.11%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.85M
6.48%
-376.85K
-6.05%
Jun 30, 2025
The Vanguard Group, Inc.
4.59M
5.08%
-135.73K
-2.87%
Jun 30, 2025
Fidelity Management & Research Company LLC
4.35M
4.82%
+40.93K
+0.95%
Jun 30, 2025
abrdn Inc.
4.20M
4.65%
+3.59M
+592.89%
Jun 30, 2025
Nantahala Capital Management, LLC
4.03M
4.47%
+1.20M
+42.39%
Jun 30, 2025
Telemark Asset Management, LLC
4.00M
4.43%
+1.00M
+33.33%
Jun 30, 2025
Columbia Threadneedle Investments (US)
2.55M
2.83%
+16.10K
+0.64%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.98M
2.19%
+52.59K
+2.73%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
Invesco NASDAQ Future Gen 200 ETF
0.43%
Inspire Small/Mid Cap ESG ETF
0.19%
iShares Micro-Cap ETF
0.04%
Fidelity Enhanced Small Cap ETF
0.03%
Invesco Nasdaq Biotechnology ETF
0.02%
iShares Biotechnology ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
Global X Russell 2000 ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Ver Mais
Invesco NASDAQ Future Gen 200 ETF
Proporção0.43%
Inspire Small/Mid Cap ESG ETF
Proporção0.19%
iShares Micro-Cap ETF
Proporção0.04%
Fidelity Enhanced Small Cap ETF
Proporção0.03%
Invesco Nasdaq Biotechnology ETF
Proporção0.02%
iShares Biotechnology ETF
Proporção0.02%
ProShares Ultra Nasdaq Biotechnology
Proporção0.02%
Global X Russell 2000 ETF
Proporção0.01%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0.01%
Proshares Ultra Russell 2000
Proporção0.01%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI